Dr. Eric K. Singhi discusses the significance of the FDA approval of subcutaneous Opdivo for patients with solid tumors.

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting ...

Peter Percy, from North Shields, admitted failing to provide a suitable living environment for four Shar Pei type dogs, three ...

Winter itch is a type of dermatitis - also known as pruritus hiemalis - that mostly occurs when the outdoor temperature drops ...

Experts shared diagnosis and management strategies for chronic pruritus at the Dermatology Days of Paris 2024 conference.

Research analysts at StockNews.com started coverage on shares of Cara Therapeutics (NASDAQ:CARA – Get Free Report) in a research report issued on Wednesday. The brokerage set a “sell” rating on the ...

Mirum Pharmaceuticals, Inc. , a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, ...

ASN-008 is under clinical development by Formation Bio and currently in Phase II for Pruritus. According to GlobalData, Phase II drugs for Pruritus have a 50% phase transition success rate (PTSR) ...